We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.83B
AUM Growth
+$365M
Cap. Flow
+$14.3M
Cap. Flow %
0.37%
Top 10 Hldgs %
46.82%
Holding
177
New
6
Increased
30
Reduced
82
Closed
1

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$20M
2
LH icon
Labcorp
LH
+$18.1M
3
SCHW
Charles Schwab
SCHW
+$10.1M
4
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$9.96M
5
WAT icon
Waters Corp
WAT
+$3.78M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$15.9M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
WMS icon
Advanced Drainage Systems
WMS
+$7.62M
4
MA icon
Mastercard
MA
+$3.36M
5
MDXG icon
MiMedx Group
MDXG
+$3.01M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Technology 13.69%
3 Healthcare 13.2%
4 Communication Services 7.56%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OTIS icon
126
Otis Worldwide
OTIS
$27.9B
$405K 0.01%
4,547
-25
-0.5% -$2.11K
LSXMK
127
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$402K 0.01%
15,850
-8,305
-34% -$186K
DIS icon
128
Walt Disney
DIS
$171B
$396K 0.01%
4,437
-408
-8% -$38.6K
BSX icon
129
Boston Scientific
BSX
$68.4B
$389K 0.01%
7,200
-8,300
-54% -$434K
USB icon
130
US Bancorp
USB
$97.9B
$377K 0.01%
11,402
-3,050
-21% -$98.6K
IBM icon
131
IBM
IBM
$213B
$335K 0.01%
2,500
– –
HCA icon
132
HCA Healthcare
HCA
$90.6B
$332K 0.01%
1,095
– –
EOG icon
133
EOG Resources
EOG
$77.7B
$316K 0.01%
2,760
– –
SDY icon
134
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$304K 0.01%
2,483
– –
ITW icon
135
Illinois Tool Works
ITW
$84.1B
$300K 0.01%
1,198
-100
-8% -$23.4K
DFS
136
DELISTED
Discover Financial Services
DFS
$299K 0.01%
2,560
– –
MO icon
137
Altria Group
MO
$125B
$276K 0.01%
6,103
– –
SO icon
138
Southern Company
SO
$108B
$274K 0.01%
3,900
– –
GEHC icon
139
GE HealthCare
GEHC
$32.7B
$262K 0.01%
3,227
– –
LBRDK icon
140
Liberty Broadband Class C
LBRDK
$4.89B
$257K 0.01%
3,209
-1,417
-31% -$110K
NVDA icon
141
NVIDIA
NVDA
$4.6T
$254K 0.01%
+6,000
New +$199K
PNC icon
142
PNC Financial Services
PNC
$99.1B
$252K 0.01%
2,000
– –
AB icon
143
AllianceBernstein
AB
$3.47B
$246K 0.01%
7,658
-400
-5% -$13.7K
VB icon
144
Vanguard Small-Cap ETF
VB
$78.9B
$242K 0.01%
1,217
-30
-2% -$5.67K
SPY icon
145
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$235K 0.01%
531
– –
ALL icon
146
Allstate
ALL
$70.6B
$233K 0.01%
2,136
-257
-11% -$29.2K
WLY icon
147
John Wiley & Sons Class A
WLY
$2.83B
$226K 0.01%
6,627
-2,200
-25% -$80.1K
AMP icon
148
Ameriprise Financial
AMP
$47.8B
$215K 0.01%
+648
New +$199K
MS icon
149
Morgan Stanley
MS
$319B
$214K 0.01%
2,500
– –
MRSH
150
Marsh
MRSH
$94.3B
$211K 0.01%
+1,120
New +$199K
3 4 5
6
7

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q2 2023 Portfolio in Review

As of Q2 2023, Beck Mack & Oliver held 177 positions worth $3.83B, up 11% from $3.46B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4%. Beck Mack & Oliver opened 6 new positions and exited 1, leaving the 177-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 39% a quarter earlier, followed by Technology and Healthcare.

  • Beck Mack & Oliver's largest Q2 2023 buy was Rush Enterprises Class A: 545,486 shares worth $22.1M.
  • Beck Mack & Oliver added most to Labcorp in Q2 2023, an estimated $18.1M increase.
  • Beck Mack & Oliver's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $15.9M.
  • Beck Mack & Oliver fully exited CAE Inc. Common Shares in Q2 2023, selling an estimated $224K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $3.83B portfolio in Q2 2023.
  • Beck Mack & Oliver opened 6 new positions and closed 1 in Q2 2023.
  • Beck Mack & Oliver's portfolio value rose 11% quarter-over-quarter to $3.83B.

Based on Beck Mack & Oliver's 13F filing for Q2 2023, filed 8 Aug 2023.